QUALITY OF LIFE AMONG CANCER PATIENTS AFTER RADIOTHERAPY AT CAN THO ONCOLOGY HOSPITAL

Thi My Ngan Truong1, Thi Thuy Trang Nguyen1, , Kim Nguyen Le1, Thu Tuyet Tran1, Do Huong Giang Nguyen1, Thị tuyết Mai Ho1, Tuyet Tram Huynh1, Thi Phuong Huynh Tran1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Quality of life is an important outcome reflecting treatment effectiveness and supportive care needs in cancer patients, especially after radiotherapy. Objectives: To identify the statement of quality of life and to explore some factors associated with the quality of life among cancer patients after radiotherapy at Can Tho Oncology Hospital in 2025. Materials and methods: A cross-sectional descriptive study was conducted on 87 inpatients with cancer who had received at least one radiotherapy session. Quality of life was assessed using the EORTC QLQ-C30 questionnaire. Data were analyzed using descriptive statistics, the Mann–Whitney U test, and the Kruskal–Wallis test. Results: The mean score global quality of life was 43.3 ± 17.9; the mean functional score was 35.9 ± 14.2; the mean symptom score was 23.3 ± 17.1; and the mean financial difficulty score was 27.6 ± 19.0. Within the functional domains, role functioning had the highest mean score (59.4 ± 30.5), while emotional functioning had the lowest score (19.3 ± 18.1). Among symptoms, insomnia (40.2 ± 34.2), appetite loss (33.3 ± 30.5), and pain (24.5 ± 23.5) were the most prominent problems. Economic status was significantly associated with global health status (p = 0.013) and financial difficulty (p = 0.010); time since diagnosis was associated with functional score (p = 0.020); and number of radiotherapy sessions was associated with symptom score (p = 0.035). Conclusion: Quality of life among cancer patients after radiotherapy remained low, particularly in emotional functioning and symptom burden. Strengthening psychological support, symptom control, and financial support is warranted. 

Article Details

References

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. Journal for Clinicians. 2024. 74(3), 229-63, doi: 10.3322/caac.21834.
2. Knez J, Sobocan M, Belak U, Kavalar R, Zupin M, et al. Pre-treatment risk assessment of women with endometrial cancer: differences in outcomes of molecular and clinical classifications in the Slovenian patient cohort. Radiol Oncol. 2021. 56(1), 76-82, doi: 10.2478/raon-2021-0036.
3. Zhang L, Su Y, Hua Y, Liu W, Yue L, et al. Validation of EORTC QLQ-LC43 for Chinese patients with lung cancer. Lung Cancer. 2014. 85(1), 94-8, doi: 10.1016/j.lungcan.2014.04.006.
4. Trần Trung Kiên, Lê Thanh Vũ. Chất lượng cuộc sống và một số yếu tố liên quan ở người bệnh ung thư điều trị tại Bệnh viện Đại học Y Dược Shing Mark. Tạp chí Y Dược học Cần Thơ. 2023. (66), 36-43, doi: 10.58490/ctump.2023i66.1763.
5. Wan C, Meng Q, Yang Z, Tu X, Feng C, et al. Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer. Annals of Oncology. 2008. 19(12), 2053-60, https://doi.org/10.1093/annonc/mdn417.
6. Dương Huy Lương, Trần Thị Lý. Một số yếu tố liên quan đến chất lượng cuộc sống của người bệnh ung thư phổi sau xạ trị tại Bệnh viện Phổi Trung ương. Tạp chí Y học Việt Nam. 2025. 552(3), 307-312, doi: https://doi.org/10.51298/vmj.v552i3.15144.
7. Nguyễn Quỳnh Tú, Vũ Thị Thu, Phạm Đình Phúc, Đào Công Ba, Đào Thị Ngọc Minh. Đánh giá chất lượng cuộc sống ở bệnh nhân ung thư tại Khoa Ung thư tổng hợp, Bệnh viện Trung ương Quân đội 108. Journal of 108 - Clinical Medicine and Pharmacy. 2022. 17(DB8), 4-12, https://doi.org/10.52389/ydls.v17iDB8.1332.